Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5

Tamura, T; Yamasoba, D; Oda, Y; Ito, J; Kamasaki, T; Nao, N; Hashimoto, R; Fujioka, Y; Suzuki, R; Wang, L; Ito, H; Kashima, Y; Kimura, I; Kishimoto, M; Tsuda, M; Sawa, H; Yoshimatsu, K; Yamamoto, Y; Nagamoto, T; Kanamune, J; Suzuki, Y; Ohba, Y; Tabata, K; Yokota, I; Matsuno, K; Takayama, K; Tanaka, S; Sato, K; Fukuhara, T

Fukuhara, T (通讯作者),Hokkaido Univ, Dept Microbiol & Immunol, Fac Med, Sapporo, Japan.;Matsuno, K; Fukuhara, T (通讯作者),Hokkaido Univ, Inst Vaccine Res & Dev, HU IVReD, Sapporo, Japan.;Sato, K (通讯作者),Univ Tokyo, Inst Med Sci, Div Syst Virol, Dept Microbiol & Immunol, Tokyo, Japan.;Tanaka, S (通讯作者),Hokkaido Univ, Dept Canc Pathol, Fac Med, Sapporo, Japan.;Takayama, K; Fukuhara, T (通讯作者),Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.;Takayama, K (通讯作者),Hokkaido Univ, Int Inst Zoonosis Control, Div Int Res Promot, Sapporo, Japan.;Matsuno, K (通讯作者),Hokkaido Univ, One Hlth Res Ctr, Sapporo, Hokkaido, Japan.;Takayama, K (通讯作者),Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan.;Tanaka, S (通讯作者),Hokkaido Univ, Inst Chem React Design & Discovery WPI ICReDD, Sapporo, Japan.;Matsuno, K (通讯作者),Hokkaido Univ, Int Inst Zoonosis Control, Int Collaborat Unit, Sapporo, Japan.;Yokota, I (通讯作者),Hokkaido Univ, Dept Biostat, Fac Med, Sapporo, Japan.;Matsuno, K (通讯作者),Hokkaido Univ, Int Inst Zoonosis Control, Div Risk Anal & Management, Sapporo, Japan.;Sato, K (通讯作者),Univ Tokyo, Grad Sch Med, Tokyo, Japan.;Sato, K (通讯作者),Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.;Sato, K (通讯作者),Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan.;Sato, K (通讯作者),Univ Tokyo, Inst Med Sci, Int Vaccine Design Ctr, Tokyo, Japan.;Sato, K (通讯作者),Kumamoto Univ, Collaborat Unit Infect, Joint Res Ctr Human Retrovirus Infect, Kumamoto, Japan.;Sato, K (通讯作者),CREST, Japan Sci & Technol Agcy, Kawaguchi, Japan.;Fukuhara, T (通讯作者),Osaka Univ, Microbial Dis Res Inst, Lab Virus Control, Suita, Japan.

COMMUNICATIONS BIOLOGY, 2023; 6 (1):

Abstract

The virological and pathological features of Omicron subvariants are compared in in vitro cellular and airway-on-a-chip and in vivo hamster models. Th......

Full Text Link